ClinicalTrials.gg
RecruitingNCT07747454Updated Aug 5, 2026

Isometric Strengthening Exercises Versus Tens in Diabetic Population

An interventional study of Isometric exercise and Transcutaneous electrical nerve stimulation in Diabetes Complications, sponsored by Kafrelsheikh University. Recruiting at 1 site in Egypt. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Study summary

This study aims to compare the effectiveness of Isometric Strengthening Exercises versus Transcutaneous Electrical Nerve Stimulation in the management of shoulder pain among individuals with diabetes mellitus.

Read the detailed description

Shoulder pain is a prevalent musculoskeletal issue in individuals with diabetes, linked to chronic hyperglycemia and altered collagen structure, leading to mobility restrictions and impaired quality of life. Despite its commonality, there is limited research on specific physiotherapy interventions, particularly isometric strengthening exercises and transcutaneous electrical nerve stimulation. Investigating these interventions is crucial due to the unique pain thresholds and healing issues in diabetic patients. This study aims to provide evidence on how isometric exercises and Transcutaneous Electrical Nerve Stimulation influence pain modulation and functional recovery, potentially optimizing rehabilitation strategies. The findings could support non-pharmacological treatments, reduce reliance on analgesics, and improve patient outcomes in managing shoulder pain in diabetic populations.

02

Conditions studied

  • Diabetes Complications
03

In context

Diabetes Complications

267 studies on the registry are indexed under Diabetes Complications; 54 are open to participants now.

This study's planned enrollment of 75 is close to the median of 72 across 171 interventional studies indexed under Diabetes Complications.

Browse Diabetes Complications studies →

Lead sponsor

Kafrelsheikh University is the lead sponsor of 294 studies on the registry; 114 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 40-65 years, diagnosed as type 2 diabetes mellitus for at least 5 years
  • Clinical diagnosis of unilateral frozen shoulder in the painful or stiff stage.
  • Limitation of passive and active range of motion in external rotation, abduction, and flexion.
  • Shoulder pain for at least 3 months.

Exclusion criteria

Exclusion Criteria:

  • Previous shoulder surgery or fracture.
  • Cervical radiculopathy or neurological disorders.
  • Rheumatoid arthritis or severe osteoarthritis.
  • Cardiac pacemaker.
  • Received injection within the last 3 months.
  • diabetes mellitus type 1
  • Participants with Vitamin B12 or D deficiency
  • Osteoarthritis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    Isometric Exercise group

    Twenty-five participants will receive the Isometric Exercise in addition to the conventional physical therapy program

    Other: Isometric exercise · Other: The conventional exercise program

  • Experimental
    Transcutaneous electrical nerve stimulation group

    Twenty-five participants will receive Transcutaneous electrical nerve stimulation in addition to a conventional physical therapy program

    Other: Transcutaneous electrical nerve stimulation · Other: The conventional exercise program

  • Active comparator
    conventional physical therapy group

    Twenty-five participants will receive conventional physical therapy program only

    Other: The conventional exercise program

Interventions

  • OtherIsometric exercise

    Isometric shoulder exercises include flexion, extension, abduction, internal and external rotation. The protocol involves holding each position for 10 seconds, resting for 5 seconds, and performing 10 repetitions in 3 sessions per week over 6 weeks. Each exercise begins from a standing position with the elbow bent at 90 degrees and a towel used for support against a wall or door frame, ensuring minimal movement and maintaining good posture throughout.

  • OtherTranscutaneous electrical nerve stimulation

    Transcutaneous electrical nerve stimulation Application Parameters: * Frequency: 80-100 Hertz * Pulse duration: 100-150 microseconds * Duration: 30 minutes * 3 sessions/week for 6 weeks Electrodes placed over the anterior and posterior shoulder.

  • OtherThe conventional exercise program

    1. Ultrasound Therapy: Administered at 3 MHz and 1.4 W/cm² for 5 minutes to improve shoulder tissue extensibility and blood circulation before exercises. 2. Codman's Pendular Exercises: Gentle passive mobilization of the glenohumeral joint is performed by allowing the affected arm to hang, aiming to reduce stiffness and pain. 3. Range of motion Exercises: Conducted within a pain-free range, progressively increasing intensity to encourage compliance. 4. Finger Ladder Exercise: Active-assisted technique for shoulder elevation, involving walking fingers up a wall. 5. Shoulder Joint Stretching Exercises: Targeting capsular tightness to improve flexibility and range of motion. Each exercise is performed in three sets of five repetitions, at least twice daily.

06

What researchers measure

Primary outcomes

  1. Assessment of shoulder range of motion

    Shoulder range of motion (ROM) for flexion, abduction, and external rotation was measured using an electrogoniometer. Participants were positioned according to standardized measurement procedures, and each movement was assessed within the participant's pain-free range. Three consecutive measurements were obtained for each motion, and the average value was recorded in degrees (°) for statistical analysis to improve measurement reliability.

    Time frame: At baseline and after 6 weeks

Secondary outcomes

  1. assessment of pain intensity

    In visual analogue scale assessment, patients were asked to place a vertical mark along a horizontal line to indicate their current degree of pain at rest and during activity, where 0 indicated 'no pain' and 100 indicated 'worst pain'.

    Time frame: At baseline and after 6 weeks

  2. assessment of activity of daily living of the upper limb

    The Disabilities of the Arm, Shoulder, and Hand questionnaire is an outcome measure designed to evaluate upper extremity functionality in daily activities, applicable to various musculoskeletal pathologies. Comprising 30 items, it measures disability and symptoms by assessing difficulties faced in physical, social, and work-related tasks, as well as their effects on sleep and self-perception regarding upper extremity issues. Patients respond using a five-point Likert scale, with scores from 1 (no difficulty) to 5 (unable to perform activity). The Disabilities of the Arm, Shoulder, and Hand questionnaire score ranges from 0 (no disability) to 100 (severest disability), and a score cannot be computed if more than three items are missing.

    Time frame: At baseline and after 6 weeks

07

Study locations

1 of 1 sites recruiting
  • Out-Patient Clinic, Faculty of Physical Therapy, Kafrelsheikh University
    Kafr ash Shaykh, Egypt
    Recruiting
    • Tairq Eisi Hedaiban Alharbi, physical therapist · Contactt18t1@hotmail.com · 00966555309550
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Dec 2026, 5 months after the start.

Of 62 non-industry interventional studies with no phase under Diabetes Complications, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 41. This study's planned 5 months is below that.

Counting every sponsor, half of 69 studies reached it within 28 months; a quarter within 12 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2026
First posted
Aug 5, 2026
StartActual
Jul 1, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Jan 1, 2027
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07747454
Responsible party
Tariq Eisi Alharbi (Principal Investigator, Kafrelsheikh University) — Principal investigator
First posted
Aug 5, 2026
Start date
Jul 1, 2026
Primary completion
Dec 1, 2026 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Aug 5, 2026

Study contacts

Tairq Eisi Hedaiban Alharbi, physical therapist
Contact
t18t1@hotmail.com
00966555309550

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion